AHEAD INTERNATIONAL AND GERMAN STUDIES: 6-YEAR INTERIM EFFECTIVENESS AND SAFETY OUTCOMES IN PATIENTS WITH HEMOPHILIA A RECEIVING ANTIHEMOPHILIC FACTOR (RECOMBINANT) IN A REAL-WORLD SETTING - Université de Rennes Access content directly
Journal Articles Haemophilia Year : 2020

AHEAD INTERNATIONAL AND GERMAN STUDIES: 6-YEAR INTERIM EFFECTIVENESS AND SAFETY OUTCOMES IN PATIENTS WITH HEMOPHILIA A RECEIVING ANTIHEMOPHILIC FACTOR (RECOMBINANT) IN A REAL-WORLD SETTING

Dates and versions

hal-02501205 , version 1 (06-03-2020)

Identifiers

Cite

J. Oldenburg, M. C. Ozelo, R. Klamroth, B. Guillet, A. Huth-Kuehne, et al.. AHEAD INTERNATIONAL AND GERMAN STUDIES: 6-YEAR INTERIM EFFECTIVENESS AND SAFETY OUTCOMES IN PATIENTS WITH HEMOPHILIA A RECEIVING ANTIHEMOPHILIC FACTOR (RECOMBINANT) IN A REAL-WORLD SETTING. Haemophilia, 2020, 26 (S2), pp.87-87. ⟨10.1111/hae.13911⟩. ⟨hal-02501205⟩
38 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More